HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

JNJ-26076713

a potent, orally bioavailable, nonpeptide alpha(V) integrin antagonist ; structure in first source
Also Known As:
(3,S,beta,S)-1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-3-quinolinepropanoic acid
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Johnson, Dana L: 1 article (03/2008)
2. Maryanoff, Bruce E: 1 article (03/2008)
3. Kinney, William A: 1 article (03/2008)
4. Galemmo, Robert A: 1 article (03/2008)
5. Zhou, Zhao: 1 article (03/2008)
6. Bursell, Sven E: 1 article (03/2008)
7. Decorte, Bart L: 1 article (03/2008)
8. Grant, Maria B: 1 article (03/2008)
9. Huebert, Norman: 1 article (03/2008)
10. Liu, Li: 1 article (03/2008)

Related Diseases

1. Retinal Neovascularization
2. Retinopathy of Prematurity (Retrolental Fibroplasia)
3. Macular Edema
4. Macular Degeneration (Age-Related Maculopathy)
5. Diabetic Retinopathy (Retinopathy, Diabetic)

Related Drugs and Biologics

1. Retinaldehyde (Retinal)
2. Oxygen

Related Therapies and Procedures

1. Oral Administration